Transaction provides up to CHF 20.0 million in near-term liquidity Financing provides funding runway to advance DMD-franchise with Puldysa® and vamorolone
Read moreA conference call will be held today at 13:00 CEST, 12:00 BST, 07:00 EDT. Details are at the end of
Read more
Pratteln, Switzerland, May 20, 2020 – Santhera Pharmaceuticals (SIX: SANN) announces full recruitment of its Phase 3 SIDEROS study with idebenone
Read more
Santhera Pharmaceuticals’s Raxone has been renewed in UK, as the nation’s Medicines and Healthcare products Regulatory Agency (MHRA) has renewed
Read more
Santhera Pharmaceuticals said on Tuesday that the Korean Ministry of Food and Drug Safety (MFDS) has accepted its new drug
Read more